Diabetic Retinopathy Market Growth, Global Survey, Analysis, Share, Company Profiles and Forecast by 2028

Rising prevalence of diabetes and increasing incidences of blindness among people with severe diabetic conditions are expected to fuel the global market growth
Market Size – USD 8,579.1 Million in 2020, Market Growth - CAGR of 7.10%, Market Trends – New product launches and increasing R&D activities
The global diabetic retinopathy market size is expected to reach USD by 14.95 Billion 2028 at a CAGR of 7.10%, according to a new report by Reports and Data. Rising prevalence of chronic conditions such as diabetes, increasing cases of diabetic retinopathy among diabetic patients, and growing preferences for technologically advanced and minimally invasive procedures are among the major factors responsible for the growth of the global diabetic retinopathy market in the upcoming years. Booming geriatric population worldwide and their growing susceptibility to chronic diseases such as diabetes, cardiovascular disorders, and sleep disorders further boost market growth to a significant extent.
Diabetic retinopathy is a severe medical condition in which diabetes affects the eyes. The principal cause of diabetic retinopathy is damage to the blood vessels of the light-sensitive tissue of the retina. The most common symptoms of this condition include blurred vision, fluctuating vision, dark or empty areas in the vision, impaired color vision, and vision loss. Excessive amount of sugar in blood leads to the blockage of the tiny blood vessels of the retina and hamper blood supply. Mild-to-moderate cases of diabetic retinopathy may be treated with the help of effective diabetes management; however, advanced cases require laser treatment or surgical procedures.

Key companies profiled in the report include
Novartis AG, Bayer Healthcare, Regeneron Pharmaceuticals Inc., ThromboGenics, Actavis Plc, Sirnaomics, Genentech, Alimera Sciences, Glycadia Pharmaceuticals, Ampio Pharmaceuticals, Kowa Group, and BCN Peptides

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1484

The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Diabetic Retinopathy market.
The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1484

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.

The key geographical regions analyzed in the market report are:
• North America (U.S.A., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Diabetic Retinopathy Market Segmentation based on Types:
Type (Revenue, USD Billion; 2020-2028)
• Mild
• Moderate
• Severe
Disease Form (Revenue, USD Billion; 2020-2028)
• Proliferative diabetic retinopathy
• Non-proliferative diabetic retinopathy
Management (Revenue, USD Billion; 2020-2028)
• Anti-VEGF
• Intraocular steroid injection
• Laser surgery
• Vitrectomy
Distribution channel (Revenue, USD Billion; 2020-2028)
• Eye clinics
• Hospitals
• Retail pharmacies
• Online pharmacies
• Ambulatory surgical centers
• Other

To know more about the report @ https://www.reportsanddata.com/report-detail/diabetic-retinopathy-market

Some Key Highlights in the Report:
• Non-proliferative diabetic retinopathy segment is projected to register the highest CAGR of 7.5% over the forecast period. Rising prevalence of non-proliferative diabetic retinopathy among diabetic patients is one of the most vital factors driving this segment’s growth.
• On the basis of management, the anti-VEGF segment dominated tin terms of revenue in 2020. The segment is expected to maintain its dominance throughout the forecast period, owing to increasing applications of anti-VEGF drugs including Eylea, Lucentis, Avastin, and Macugen in the treatment of mild-to-moderate cases of diabetic retinopathy is one of the key factors accountable for the growth of this segment.
• Among the various distribution channels, the hospitals segment held the largest revenue share in the global diabetic retinopathy market in 2020. Increasing availability of diagnostic instruments in hospitals and pharmacies worldwide and growing number of treatment procedures for diabetic retinopathy bolster the growth of this segment.
• The North America diabetic retinopathy market is the most dominant regional market in terms of revenue. Growing prevalence of diabetes, increasing use of anti-VEGF drugs including Avastin, Eylea, and Lucentis for diabetic retinopathy, rising patient awareness, and the presence of state-of-the-art healthcare infrastructure in North America are the primary factors accountable for the regional market growth. The Asia Pacific market is the fastest-growing regional market and is expected to display a robust CAGR of 8.3% over the forecast period.

Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/1484

Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.

Browse More Reports:

Veterinary Artificial Insemination Market @ https://www.google.com.bh/url?q=https://www.reportsanddata.com/report-detail/veterinary-artificial-insemination-market

Cell Therapy Laboratory Equipment Market @ https://www.google.md/url?q=https://www.reportsanddata.com/report-detail/cell-therapy-laboratory-equipment-market

Bovine Blood Plasma Derivatives Market @ https://www.google.co.zw/url?q=https://www.reportsanddata.com/report-detail/bovine-blood-plasma-derivatives-market

mRNA Cancer Vaccines And Therapeutics Market @ https://www.google.com.fj/url?q=https://www.reportsanddata.com/report-detail/mrna-cancer-vaccines-and-therapeutics-market

Peptide Cancer Vaccine Market @ https://www.google.bf/url?q=https://www.reportsanddata.com/report-detail/peptide-cancer-vaccine-market

Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.